Tifenazoxide

DB21402InvestigationalSmall molecule

Tifenazoxide is a small molecule drug. Tifenazoxide is under investigation in clinical trial NCT04744129 (Headache Inducing Effect of NN414 in Migraine Patients). Tifenazoxide has a monoisotopic molecular weight of 290.99...

Formula / weight: C₉H₁₀ClN₃O₂S₂ · 291.77 g/mol (avg)
Code names: NN-414

Resolves to

Compound

UNIIY79681GLMGCAS279215-43-9ChEMBLCHEMBL135191

Structure

InChIKeyKYSFUHHFTIGRJN-UHFFFAOYSA-NSMILESCC1(CC1)NC1=NS(=O)(=O)C2=C(N1)C=C(Cl)S2

Targets

Q09428ABCC8

What you can answer from here — as of September 13, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Tifenazoxide, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account